Suvorexant Uspi - Belsomra - fda prescribing information, side effects , Belsomra ® (suvorexant) is indicated for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance.. belsomra dosage and administration dosing information. use the lowest dose effective for the patient. the recommended dose for belsomra is 10 mg, taken no more than once per night and within 30 minutes of going to bed, with at least 7 hours remaining. Triazolam - wikipedia, Triazolam (original brand name halcion) is a central nervous system (cns) depressant in the benzodiazepine class. it possesses pharmacological properties similar to those of other benzodiazepines, but it is generally only used as a sedative to treat severe insomnia. in addition to the hypnotic properties, triazolam's amnesic, anxiolytic, sedative, anticonvulsant and muscle relaxant properties.